Literature DB >> 9126058

The phenotypic manifestations of chromosome 17p11.2 duplication.

P K Thomas1, W Marques, M B Davis, M G Sweeney, R H King, J L Bradley, J R Muddle, J Tyson, S Malcolm, A E Harding.   

Abstract

Clinical and electrophysiological investigations and nerve biopsies were carried out on 61 patients shown to have a chromosome 17p11.2 duplication (hereditary motor and sensory neuropathy-HMSN Ia). Of these, 50 showed a Charcot-Marie-Tooth (CMT) phenotype and eight could be classified as having the Roussy-Lévy syndrome. Of the patients with a CMT phenotype, three had associated pyramidal signs and of these one had 'complicated' HMSN and also signs of cerebellar and bulbar involvement. Diaphragmatic weakness was present in three severely affected cases, one of whom also had denervation of the anal sphincter associated with faecal incontinence. One unusual case presented in middle life with incapacitating muscle cramps associated with calf hypertrophy and only mild clinical signs of neuropathy. Prominent distal sensory loss was a consistent feature in one family, resulting in acrodystrophic changes in several members. Concurrent focal peripheral nerve lesions were seen with both the CMT and Roussy-Lévy phenotypes, in seven patients. Upper limb motor nerve conduction velocity was 19.9 m/s +/- 1.3 (SEM), range 5-34 m/s. This corresponds to values previously obtained for autosomal dominant HMSN I. This series consisted mainly of older patients with more advanced disease. In contrast to the findings in younger patients, in their nerve biopsies, myelin thickness tended to be relatively reduced for axon size, indicating remyelination and/or hypomyelination; there was also regression of the onion bulbs. It is concluded that the possession of two copies of the peripheral myelin protein 22 gene within the duplicated region on chromosome 17p gives rise to a range of phenotypes and not solely to a CMT syndrome, and that the pattern of histological change in the peripheral nerves alters with advance of the disease.

Entities:  

Mesh:

Year:  1997        PMID: 9126058     DOI: 10.1093/brain/120.3.465

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  56 in total

1.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.

Authors:  I V Mersiyanova; A V Perepelov; A V Polyakov; V F Sitnikov; E L Dadali; R B Oparin; A N Petrin; O V Evgrafov
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

2.  Comparison of CMT1A and CMT2: similarities and differences.

Authors:  Henriette M E Bienfait; Camiel Verhamme; Ivo N van Schaik; Johannes H T M Koelman; Bram W Ongerboer de Visser; Rob J de Haan; Frank Baas; Baziel G M van Engelen; Marianne de Visser
Journal:  J Neurol       Date:  2006-08-28       Impact factor: 4.849

3.  Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A.

Authors:  Robert Fledrich; Ruth M Stassart; Axel Klink; Lennart M Rasch; Thomas Prukop; Lauren Haag; Dirk Czesnik; Theresa Kungl; Tamer A M Abdelaal; Naureen Keric; Christine Stadelmann; Wolfgang Brück; Klaus-Armin Nave; Michael W Sereda
Journal:  Nat Med       Date:  2014-08-24       Impact factor: 53.440

4.  Therapeutic strategies for the inherited neuropathies.

Authors:  Michael E Shy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 5.  Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies.

Authors:  Kinga Szigeti; Eva Nelis; James R Lupski
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  A novel point mutation in the PMP22 gene in a family with Roussy-Levy syndrome.

Authors:  S Zubair; N R Holland; B Beson; J T Parke; C I Prodan
Journal:  J Neurol       Date:  2008-07-07       Impact factor: 4.849

7.  Respiratory dysfunction in Charcot-Marie-Tooth disease type 1A.

Authors:  Mônica de Carvalho Alcântara; Marcello H Nogueira-Barbosa; Regina Maria França Fernandes; Geruza Alves da Silva; Charles Marques Lourenço; Heide H Sander; Wilson Marques Junior
Journal:  J Neurol       Date:  2015-03-13       Impact factor: 4.849

Review 8.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

9.  Anterior tibialis CMAP amplitude correlations with impairment in CMT1A.

Authors:  Kelsey Komyathy; Stephanie Neal; Shawna Feely; Lindsey J Miller; Richard A Lewis; George Trigge; Carly E Siskind; Michael E Shy; Sindhu Ramchandren
Journal:  Muscle Nerve       Date:  2013-03-03       Impact factor: 3.217

10.  PMP22 expression in dermal nerve myelin from patients with CMT1A.

Authors:  Istvan Katona; Xingyao Wu; Shawna M E Feely; Stephanie Sottile; Carly E Siskind; Lindsey J Miller; Michael E Shy; Jun Li
Journal:  Brain       Date:  2009-05-15       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.